LC determination of octreotide acetate in compound formulations of Sandostatin(®) and diamorphine hydrochloride

Journal of Pharmaceutical and Biomedical Analysis

Volumn 21, Issue 2, 1999, Pages 327-330

  Kyaterekera, N ^a   Tettey, J N A ^a   Skellern, G G ^a   Watson, D G ^a   Urie, J ^b   McDade, J R ^c   Fielding, H ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c NHS LOTHIAN   (United Kingdom)

Author keywords

Degradants; Diamorphine hydrochloride; Octreotide acetate; Reversed phase LC

Indexed keywords

DIAMORPHINE; MORPHINE 6 ACETATE; OCTREOTIDE;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG STRUCTURE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

BUFFERS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; HEROIN; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; OCTREOTIDE;

EID: 0032717235     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00123-5     Document Type: Article

References (4)

1. Katz M.D., Erstad B.L. Clin. Pharm. 8:1989;255-301.
2. Riley J., Fallon M.T. Eur. J. Palliative Care. 1:1994;23-25.
3. Ripley R.G., Ritchie D.J., Holstad S.G. Am. J. Health-Syst. Pharm. 52:1995;1910-1911.
4. Barrett D.A., Shaw P.N. J. Liquid Chromatogr. 17:1994;3727-3733.